FDA: 10 mg doses of Xeljanz increase risk for blood clots, death in RA - Healio

FDA: 10 mg doses of Xeljanz increase risk for blood clots, death in RA  Healio

The FDA has issued a safety alert regarding a clinical study that has found a 10-mg, twice-daily dose of tofacitinib increased the risk for pulmonary embolism and ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases